India’s cancer focus must shift to early detection
This article argues that India's cancer strategy must shift from tertiary treatment to early detection to improve survival rates and reduce economic burdens on households. It highlights that late-stage diagnosis is a primary driver of both poor medical outcomes and catastrophic healthcare expenditure.
Why it matters
Addressing the late-stage diagnosis crisis is essential for improving public health outcomes and economic stability in India, where cancer incidence is rising.
E very day, oncology clinics across India confront the same heartbreaking reality. More than 70% of patients present with advanced-stage cancer, when treatment is more complex, more expensive, and far less likely to achieve a cure. Over the past two decades, India has invested substantially in building world-class tertiary cancer centres and has expanded access to sophisticated surgery, radiation therapy, and systemic treatments. Yet these advances cannot deliver their full potential because most patients arrive too late.
The solution to this challenge lies upstream.
Cancer in India is still diagnosed predominantly after symptoms become severe enough to disrupt daily life. By then, opportunities for curative treatment have often been lost. The consequences extend far beyond health. More than three-quarters of cancer-affected households experience catastrophic healthcare expenditure. Late diagnosis is therefore not only a medical problem — it also drives poverty.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in